Shire Articles
US FDA approves Shire’s ADHD drug Intuniv
4 September 2009
Intuniv cuts symptoms in ADHD children
26 May 2009
Shire sales up 20% pre-Adderall demise
1 May 2009
Stock Commentary - Europe - week to April 13, 2009
16 April 2009
Renovo surges 32% on takeover talks
7 April 2009
Shire files Fosrenol law suit against Natco Pharma
6 April 2009
GSK/Shire Vyvanse deal fuels speculation
1 April 2009
Stock Commentary - Europe - week to March 23, 2009
30 March 2009
Shire recalls 39 lots of Daytrana due to design flaws
30 March 2009
Cosmo's 2008 profit jumps 5.2% to $12.9M
30 March 2009
Shire files law suit to block Mylan's generic Fosrenol
30 March 2009
Mylan group sued over for first-to-file ANDAs
27 March 2009
Shire sues Barr over Fosrenol patents
23 March 2009
Shire withdaws EU Daytrana MAA
23 March 2009
Stock Commentary - Europe - week to Mar 9, 2009
16 March 2009
Shire launches Fosrenol in Japan
16 March 2009
Amicus drops 32.5% as it halts Ph II AT2220 trial
9 March 2009
Agility and innovation, at Economist
9 March 2009
Shire buys ADHD drugs from UCB
2 March 2009
Shire representative office opens in Japan
2 March 2009
DxS appoints Jeff Devlin as COO
16 February 2009
Shire told Mylan and Barr seeking generic Fosrenol appro
16 February 2009
Stock Commentary - Europe - week to Jan 19, 2009
26 January 2009
Highlights of first PDCO meeting of 2009
26 January 2009
Pharma/biotech mergers and acquisitions in 2008
12 January 2009
Stock Commentary - Europe - week to Jan 5, 2009
12 January 2009
US FDA swoops on YouTube "DTC abuse"
8 December 2008
Stock Commentary - Europe - week to Dec 1, 2008
8 December 2008
Shire's HGT unveils ambitious growth plan, doubling sales contribution to 30% by 2015
1 December 2008
Stock Commentary - Europe - week to Nov 17, 2008
24 November 2008
Stock Commentary - Europe - week to Nov 3, 2008
10 November 2008
3rd-qtr new product sales deliver for Shire, but the firm posts earnings drop on charges
10 November 2008
EC approves Shire/Jerini's Firazyr
20 October 2008
Stock Commentary - Europe - week to Oct 6, 2008
13 October 2008
Shire's Lialda shows sustained 5-ASA release
13 October 2008
Shire's Vyvanse projected to gain blockbuster status by 2017
13 October 2008
TRIPs mechanism set to fail as Apotex ships ARV
29 September 2008
Almirall's first-half sales boosted by acquisitions
8 September 2008
Sepracor names new VPs: Richard Ranieri and Julio Casoy
1 September 2008
Shire now holds 81% of Jerini
18 August 2008
Noven gets final $25M Shire milestone
11 August 2008
Shire ups forecast on strong 2nd qtr
11 August 2008
Cosmo's first-half 2008 results beat forecasts
11 August 2008
Stock Commentary - Europe - week to July 21, 2008
28 July 2008
UK doctors debate NHS drug top-ups
14 July 2008
UK doctors debate NHS drug top-ups
14 July 2008
Stock Commentary - Europe - week to June 23, 2008
30 June 2008
DEA block to US e-Rx adoption set to end
30 June 2008
Shire appoints Graham Hetherington as cfo
16 June 2008
Shire
2 June 2008
Court approves Shire scheme of arrangement
2 June 2008
Hikma may follow Shire away from UK
26 May 2008
Pharma M&A rumor mill in top gear
26 May 2008
Almirall's 1st-qtr net income falls 9.9%
26 May 2008
Shire's Vyvanse improves ADHD in adults
19 May 2008
Shire: strong 1st qtr, wary over new drug
5 May 2008
Shire buys rights to Metazym for $135M
5 May 2008
Shire's Vyvanse cleared for ADHD in adults
28 April 2008
Shire move to improve CKD management adherence
7 April 2008
Shire signs US co-promotion deal with TAP for Lialda
31 March 2008
Stock Commentary - Europe - week to March 24, 2008
31 March 2008
LB analysts: Shire is "heavily" over-valued
31 March 2008
SMC approves Shire's Mezavant XL for UC
24 March 2008
Is Pfizer eyeing up UK's Shire for acquisition?
24 March 2008
Stock Commentary - Europe - week to March 17, 2008
24 March 2008
Shire debuts UC education forum in USA
17 March 2008
Cosmo's 2007 profit beats estimates
10 March 2008
Stock Commentary - Europe - week to Feb 25, 2008
3 March 2008
CORRECTION: P&G's Asacol trial
25 February 2008
Stock Commentary - Europe - week to Feb 11, 2008
18 February 2008
Shire's Elaprase cleared in Mexico
18 February 2008
P&G's Asacol launched in UK for UC
18 February 2008
Spain's Almirall opens affiliate in UK
11 February 2008
Stock Commentary - Europe - week to Feb 4, 2008
11 February 2008
Shire expands Latin America operations
21 January 2008
Stock Commentary - Europe - week to Jan 14, 2008
21 January 2008
India patent battle over Tarceva opens new CL front
21 January 2008
Shire licenses Alba's GI drug in $325M deal
24 December 2007
Angus Russell names as new Shire CEO
17 December 2007
New Rxing info for carbamazepine agreed
17 December 2007
Almirall's COPD drug aclidinium bromide is a potential jewel in the company's crown
10 December 2007
Amicus and Shire sign drug development deal
19 November 2007
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
